☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Amgen
Insights+: The US FDA New Drug Approvals in November 2023
December 20, 2023
Amgen Report Results for ABP 959 in Clinical Trial for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
December 6, 2023
Insights+: The US FDA New Drug Approvals in October 2023
November 15, 2023
Amgen Reports P-IV (FOREMOST) Trial Results Evaluating Otezla (apremilast) for the Treatment of Early Oligoarticular Psoriatic Art...
November 9, 2023
Amgen Receives the US FDA’s Approval of Wezlana (Biosimilar, ustekinumab) for the Treatment of Multiple Inflammatory Diseases
November 1, 2023
Amgen Presents P-III Data for Lumakras and Vectibix in Metastatic Colorectal Cancer at ESMO 2023
October 23, 2023
Load more...
Back to Home